Abstract:Vascular endothelial cells produce various biologically active factors regulating blood pressure, coagulation, and possibly cell growth of the vascular wall. Of the factors, nitric oxide (NO) has been the object of attention because of its quite simple molecular structure and variety of biological functions. In the present review, we focused on the physiologic and pathologic aspects of NO in hypertension. In experimental animals, both acute and chronic inhibition of NO synthase (NOS) with arginine derivatives produce a significant rise in blood pressure, indicating that tonic production of NO regulates basal vascular tonus. The chronic hypertension caused by NOS inhibitor is associated with cardiac hypertrophy and renal insufficiency. Sodium retention, though transient, and the plasma and tissue renin/angiotensin system in addition to the reduced production of NO have been implicated in the development of hypertension. Hypertension and the associated target organ failure can be reversed by co-administration of L-arginine or blockades of the renin/angiotensin system. Studies in which L-arginine as the substrate of NO or NOS inhibitor was administered demonstrated an important role of NO in the regulation of tonic vascular tonus also in normal subjects. In hypertensive subjects, however, endothelium-dependent vasorelaxation and production of NO are impaired, possibly due to a deficiency of L-arginine and/or a disorder of its utilization. Recent advances in the methods of detecting NO enabled us to demonstrate its diminished production from endothelial cells of hypertensive rats in vitro, although no definite biochemical evidence has been obtained in hypertensive subjects. The endothelial dysfunction, however, is not a primary cause of hypertension but a secondary result since it is commonly observed in various types of hypertension and can be reversed by correcting the blood pressure. Other common diseases including atherosclerosis and diabetes mellitus are also associated with similar abnormalities of the endothelium. NO has anti-atherogenic actions: inhibition of platelet functions and proliferation of vascular smooth muscle cells. Therefore, potentiation of endogenous NO and/or supplement of exogenous NO donors could be novel therapeutic approaches for the treatment of hypertension and atherosclerosis, while potential adverse effects of NO including cytotoxicity, immunosuppressibility, and hypotensive shock should be taken into account.

Clinical Studies of L-Arg Effect on Essential Hypertension

Effect of Astragalus Membranaceus on Hypertenison and Mechanisms Investigation in Spontaneously Hypertensive Rats

Effect of Oral L-Arginine Supplementation on Blood Pressure: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

Clinical Effects of Arotinolol in Patients with Essential Hypertension

The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure

Changes in L-arginine/NO Pathway of Erythrocytes in Patients with Essential Hypertension

[Clinical significance of nitric oxide in hypertension]

Change of L-Arg/NO system in erythrocytes of essential hypertension patients

Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients

[Changes of Serum Asymmetric Dimethylarginine in Essential Hypertension Before and after the Treatment].

Changes of L-arginine Transportation in Blood System of Patients with Essential Hypertension

Assessment of Registered Clinical Trial Designs: Comparison of L-Arginine and/or L-Citrulline Interventions for Hypertension

Lowering Effects of N-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial.

L-Arginine Improves Endothelial Function in Renal Artery of Hypertensive Dahl Rats

The Effect of L-arginine on High Pulmonary Blood Flow-Induced Pulmonary Hypertension

509 L-CITRULLINE SUPPLEMENTATION REDUCED PERIPHERAL BLOOD PRESSURE IN CHINESE ADULTS WITH PREHYPERTENSION

[Relationship Between Angiopoietin-2 and Vascular Endothelial Factor and Vasodilation Function in Hypertensive Patients].

L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.

Effect of levamlodipine besylate on vascular function in patients with mild-to-moderate hypertension

Clinical Study on Therapeutic Effect and Adjustment to Plasma CGRP and NO in the Patient of Essential Hypertension with Scalp Penetration Acupuncture

Studies on L-arginine Anti-Oxidative Injury in Endothelial Cells